MYGN · Myriad Genetics Inc · Documents
Market Cap
$327.12M
Shares
95.65M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-09-10 | 2026-09-30 | |
| 10-Q | 2026-07-31 | 2026-06-30 | |
| 8-K | 2026-07-30 | — | |
| 8-K | 2026-06-23 | 2026-06-17 | |
| 8-K | 2026-06-04 | — | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| 8-K | 2026-05-05 | — | |
| DEF 14A | 2026-04-14 | 2025-12-31 | |
| 10-K | 2026-02-24 | 2025-12-31 | |
| 8-K | 2026-02-23 | — | |
| 8-K | 2026-01-12 | — | |
| 10-Q | 2025-11-04 | 2025-09-30 | |
| 8-K/A | 2025-11-04 | 2025-11-03 | |
| 8-K | 2025-11-03 | — | |
| 8-K | 2025-10-07 | 2025-10-01 | |
| 8-K | 2025-10-03 | 2025-09-29 | |
| 8-K | 2025-08-18 | 2025-08-15 | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-08-05 | — | |
| 8-K | 2025-07-31 | — | |
| 8-K | 2025-06-05 | — | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| 8-K | 2025-05-06 | — | |
| DEF 14A | 2025-04-09 | 2024-12-31 | |
| 10-K | 2025-02-28 | 2024-12-31 | |
| 8-K | 2025-02-24 | — | |
| 8-K | 2025-01-15 | — | |
| 8-K | 2024-12-10 | — | |
| 8-K | 2024-11-26 | — | |
| 10-Q | 2024-11-08 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-10-09 | — | |
| 8-K | 2024-09-04 | — | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-08-06 | — | |
| 8-K | 2024-06-06 | — | |
| 8-K | 2024-06-03 | — | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| 8-K | 2024-05-07 | — | |
| DEF 14A | 2024-04-17 | 2023-12-31 | |
| 10-K | 2024-02-28 | 2023-12-31 | |
| 8-K | 2024-02-27 | — | |
| 8-K | 2024-01-16 | 2024-01-10 | |
| 8-K | 2023-12-21 | 2023-12-15 | |
| 8-K | 2023-11-13 | 2023-11-08 | |
| 8-K | 2023-11-09 | 2023-11-08 | |
| 10-Q | 2023-11-07 | 2023-09-30 | |
| 8-K | 2023-11-06 | — | |
| 8-K | 2023-11-01 | — | |
| 8-K | 2023-10-31 | — |
Showing 1–50 of 111 filings
Key facts
CIK
899923
CUSIP
62855J104
13F (30d)
102 filings
102 filers
Visit website
Investor relations